Viking Therapeutics, Inc. ($VKTX)
ZANTE GREG โ Chief Financial Officer
Shares
91,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | ZANTE GREG |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Jan 2, 2026 |
| Expiration Date | Jan 2, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Shares Purchased | 91,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 91,000 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-003116 |
| Document | View SEC Filing |